Skip to main content
SpringerLink
Log in

Insulin secretion in hyperlipoproteinemias

  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

Insulin secretion has been evaluated after oral glucose loading and other stimuli (tolbutamide, glucagon, arginine and i.v. glucose) in a group of 3 patients with familial hyperchylomicronemia (Fredrickson’s Type I), 33 patients with primary hypercholesterolemia (Fredrickson’s Type II) and 89 patients with endogenous hypertriglyceridemia. In familial hyperchylomicronemia glucose tolerance and insulin secretion were normal. In patients with familial hypercholesterolemia the increased insulin secretion is conditioned by overweight. In hypertriglyceridemic patients no significant correlation has been observed after glucose loading between basal insulin and plasma triglycerides and between insulin response (insulin area) and plasma triglyceride levels. Mean insulin response to oral glucose was significantly increased in hypertriglyceridemic patients with normal glucose tolerance and still more in hypertriglyceridemic patients with chemical diabetes. A significant positive correlation has been found between overweight and insulin response after oral glucose in the hypertriglyceridemic patients with normal glucose tolerance. The insulin response after the other stimuli was not significantly different from that of the controls. In conclusion, in primary familial hypercholesterolemia, insulin secretion was increased after oral glucose, with normal glucose tolerance; overweight only partially explained the increased insulin response. In endogenous hypertriglyceridemia, plasma triglycerides were not related to the degree of insulin response after oral glucose. Overweight is related to insulin response only when glucose tolerance is still normal, but with the appearance of a diabetic state, insulin secretion seems to be conditioned by the reduced glucose tolerance. Increased insulin secretion seems to be the first alteration of glucose homeostasis, even in the presence of normal glucose tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abrams M. E., Jarrett R., Keen H., Boyns D. R., Crossley J. N.: Oral Glucose Tolerance and Related Factors in a Normal Population Samples. II. Interrelationship of Glycerides, Cholesterol and Other Factors with the Glucose and Insulin Response — Brit. med. J.1, 599, 1969.

    Article  PubMed  CAS  Google Scholar 

  2. Albrink M., Davidson P. C.: Impaired Glucose Tolerance in Patients with Hypertriglyceridemia — J. Lab. clin. Med.67, 573, 1966.

    CAS  Google Scholar 

  3. Avogaro P., Crepaldi G., Enzi G., Tiengo A.: Association of Hyperlipidemia, Diabetes Mellitus and Mild Obesity — Acta diabet. lat.4, 572, 1967.

    Article  Google Scholar 

  4. Bagdade J. D., Bierman E. L., Porte D. Jr.: Influence of Obesity on the Relationship between Insulin and Triglyceride Levels in Endogenous Hypertriglyceridemia — Diabetes20, 664, 1971.

    PubMed  CAS  Google Scholar 

  5. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T.: Classification of Hyperlipidemias and Hyperlipoproteinemias — Bull. Wld Hlth Org.43, 891, 1970.

    CAS  Google Scholar 

  6. Bierman E. L., Bagdade J. D., Porte D. Jr.: Obesity and Diabetes: the Odd Couple - Amer. J. clin. Nutr.21, 1434, 1968.

    PubMed  CAS  Google Scholar 

  7. Bierman E. L., Porte D. Jr.: Carbohydrate Intolerance and Lipemia — Ann. intern. Med.68, 926, 1968.

    PubMed  CAS  Google Scholar 

  8. Bottger I., Faloona G., Unger R.: Response of Islet Cell and Gut Hormones to Fat Absorption: an Enteroinsular Axis for Fat — Clin. Res.20, 542, 1972.

    Google Scholar 

  9. Brown D. F., Doyle J. T.: Pre-Beta Lipoproteinemia. Its Bearing on the Dietary Management of Serum Lipid Disorders as Related to Ischemic Heart Disease — Amer. J. clin. Nutr.20, 324, 1967.

    PubMed  CAS  Google Scholar 

  10. Brown W. V., Greten H.: Type I Hyperlipoproteinemia — In:Rifkind B. (Ed.): Disorders of Lipid Metabolism — Clin. Endocr. Metab.2, 73, 1973.

    Article  CAS  Google Scholar 

  11. Crespin S. A., Greenough W. B., Boynton D., Steinberg D.: Direct Stimulation of Insulin Secretion in Vivo by Free Fatty Acids — Diabetes18, 326, 1969.

    Google Scholar 

  12. Davidson P. C., Albrink M. J.: Abnormal Plasma Insulin Response with High Plasma Triglycerides Independent of Clinical Diabetes or Obesity — J. clin. Invest.45, 1000, 1966.

    Google Scholar 

  13. Debry G., Laurent L., Guisard D., Gonand J. P., Mejean L., Drouin P.: Étude de la glycorégulation au cours des hypertriglycéridémies essentielles — Journées Annuelles de Diabétologie de l’Hôtel-Dieu, Paris 1970. Flammarion Éd., Paris, 1970; p. 229.

  14. De Gennes J.-L., Truffert J., Salmon D.: Place des troubles de la glycorégulation dans le différentes variétés d’hyperlipidémies idiopathiques — Journées Annuelles de Diabétologie de l’Hôtel-Dieu, Paris 1970. Flammarion Éd., Paris, 1970; p. 247.

  15. Eaton R. P., Nye W. H. R.: The Relationship between Insulin Secretion and Triglyceride Concentration in Endogenous Lipemia — J. Lab. clin. Med.5, 682, 1973.

    Google Scholar 

  16. Eggstein M., Kreutz F. H.: Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe. I. — Klin. Wschr.44, 262, 1966.

    Article  PubMed  CAS  Google Scholar 

  17. Farquhar J. W., Frank A., Gross R. C., Reaven G. M.: Glucose, Insulin and Triglyceride Responses to High and Low Carbohydrate Diets in Man — J. clin. Invest.45, 1648, 1966.

    PubMed  CAS  Google Scholar 

  18. Fedele D., Tiengo A., Muggeo M., Crepaldi G.: Insulin Secretion in Human Endogenous and Experimental Hypertriglyceridemia — 3rd Int. Symposium on Atherosclerosis, Berlin 1973; abstract # 189.

  19. Ford S. Jr., Bozian R. C., Knowles H. C. Jr.: Interactions of Obesity, and Glucose and Insulin Levels in Hypertriglyceridemia — Amer. J. clin. Nutr.21, 904, 1968.

    PubMed  Google Scholar 

  20. Fredrickson D. S., Levy R. I., Lees R. S.: Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders — New Engl. J. Med.276, 34, 94, 148, 215, and 273, 1967.

    Article  PubMed  CAS  Google Scholar 

  21. Glueck C. J., Levy R. I., Fredrickson D. S.: Immunoreactive Insulin, Glucose Tolerance and Carbohydrate Inducibility in Types II, III, IV, and V Hyperlipoproteinemia — Diabetes18, 739, 1969.

    PubMed  CAS  Google Scholar 

  22. Gomez F., Jequier E., Chabot V., Buber V., Felber J.-P.: Carbohydrate and Lipid Oxidation in Normal Human Subjects: its Influence on Glucose Tolerance and Insulin Response to Glucose — Metabolism21, 381, 1972.

    Article  PubMed  CAS  Google Scholar 

  23. Hales C. N., Randle P. J.: Immunoassay of Insulin with Insulin-Antibody Precipitate — Biochem. J.88, 137, 1963.

    PubMed  CAS  Google Scholar 

  24. Heinberg M., van Harken D. R., Brown T. O.: Hepatic Lipid Metabolism in Experimental Diabetes. II. Incorporation of 1-14C-Palmitate into Lipids of the Liver and of the D less than 1,020 Perfusate Lipoproteins — Biochem. biophys. Acta (Amst.)137, 435, 1967.

    Google Scholar 

  25. Huggett A. G., Nixon D. A.: Use of Glucose Oxidase, Peroxidase and O-Dianisidine in Determination of Blood and Urinary Glucose — Lancet2, 368, 1957.

    Article  Google Scholar 

  26. Kane J. P., Longcope C., Pavlatos F. Ch., Grodsky G. M.: Studies of Carbohydrate Metabolism in Idiopathic Hypertriglyceridemia — Metabolism14, 471, 1965.

    Article  PubMed  CAS  Google Scholar 

  27. Kinsell L. W., Schlierf G.: Alimentary and Non-Alimentary Hyperglyceridemia — Ann. N. Y. Acad. Sci.131, 603, 1965.

    Article  PubMed  CAS  Google Scholar 

  28. Kuo P. T., Feng L.: Study of Serum Insulin in Atherosclerotic Patients with Endogenous Hypertriglyceridemia (Type III and IV Hyperlipoproteinemia) — Metabolism19, 372, 1970.

    Article  PubMed  CAS  Google Scholar 

  29. Levy R. I., Glueck C. J.: Hypertriglyceridemia, Diabetes Mellitus and Coronary Vessel Disease — Arch. intern. Med.123, 220, 1969.

    Article  PubMed  CAS  Google Scholar 

  30. Lewis B., Mancini M., Mattoch M., Niteckis N.: Studies on the Mechanism of Carbohydrate Induced Lipemia in Normal Man — Clin. Sci.38, 33, 1970.

    Google Scholar 

  31. Nestel P. J.: Turnover of Plasma Esterified Cholesterol: Influence of Dietary Fat and Carbohydrate and Relation to Plasma Lipids and Body Weight — Clin. Sci.38, 593, 1970.

    PubMed  CAS  Google Scholar 

  32. Noble R. P.: Electrophoretic Separation of Plasma Lipoproteins in Agarose Gel — J. Lipid Res.9, 693, 1968.

    PubMed  CAS  Google Scholar 

  33. Olefsky J., Reaven G. M., Farquhar J. W.: Effects of Weight Reduction on Obesity. Studies of Lipid and Carbohydrate Metabolism in Normal and Hyperlipoproteinemic Subjects — J. clin. Invest.53, 64, 1974.

    Article  PubMed  CAS  Google Scholar 

  34. Owen W. C., Kreisberg R. A., Siegal A. M.: Carbohydrate-Induced Hypertriglyceridemia: Inhibition by Phenformin — Diabetes20, 739, 1971.

    PubMed  CAS  Google Scholar 

  35. Patrassi G., Crepaldi G.: Le iperlipoproteinemie — Pozzi Ed., Roma, 1971.

  36. Pin-Sunyer F. X., Hashim S. A., van Itallie T. B.: Insulin and Ketone Responses to Ingestion of Medium and Long-Chain Triglycerides in Man — Diabetes18, 96, 1969.

    Google Scholar 

  37. Raskin P., Siperstein M. D.: Hyperlipidemia and Diabetes Mellitus: Can Electron Microscopy Help in the Diagnosis? — Mt. Sinai J. Med.40, 350, 1973.

    PubMed  CAS  Google Scholar 

  38. Reaven G. M., Lerner R. L., Stern M. P., Farquhar J. W.: Role of Insulin in Endogenous Hypertriglyceridemia — J. clin. Invest.46, 1756, 1967.

    PubMed  CAS  Google Scholar 

  39. Sailer S., Bolzano K., Sandhofer F., Spath P., Braunsteiner H.: Triglyceridespiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierten Hypertriglyceridämie — Schweiz. med. Wschr.98, 1512, 1968.

    PubMed  CAS  Google Scholar 

  40. Sailer S., Sandhofer F., Braunsteiner H.: Overweight and Triglyceride Level in Normal Persons and Patients with Diabetes Mellitus — Metabolism15, 135, 1966.

    Article  PubMed  CAS  Google Scholar 

  41. Salans L. B., Reaven G. M.: Effect of Insulin Pretreatment on Glucose and Lipid Metabolism of Liver Slices from Normal Rats — Proc. Soc. exp. Biol. (N. Y.)122, 1208, 1966.

    CAS  Google Scholar 

  42. Sandhofer F., Bolzano K., Sailer S., Braunsteiner H.: Quantitative Untersuchungen über den Einbau von Plasmaglucose-Kohlenstoff in Plasmatriglyceride und die Veresterungsrate von freien Fettsäuren des Plasmas zu Plasmatriglyceriden wahrend oraler Zefuhr von Glucose bei primärer kohlenhydratinduzierter Hypertriglyceridämie — Klin. Wschr.47, 1086, 1969.

    Article  PubMed  CAS  Google Scholar 

  43. Schnatz J. D., Borse R. J., Frohman L. A.: Endogenous Hypertriglyceridemia: Effects of Altering Insulin Secretion with Diazoxide and Tolbutamide — Clin. Res.16, 555, 1968.

    Google Scholar 

  44. Seyffert W. A. Jr., Madison L. L.: Physiologic Effects of Metabolic Fuels on Carbohydrate Metabolism. Acute Effect of Elevation of Plasma Free Fatty Acids on Hepatic Glucose Output, Peripheral Glucose Utilization, Serum Insulin and Plasma Glucagon Levels — Diabetes16, 765, 1967.

    PubMed  CAS  Google Scholar 

  45. Tiengo A., Crepaldi G., Muggeo M., Avogaro P., Enzi G., Trisotto A., Federspil G.: Insulin Response after Oral Glucose Load and Intravenous Tolbutamide in Patients with Fat-Induced and Carbohydrate-Induced Hyperlipemias — Acta diabet. lat.4, 591, 1967.

    Article  Google Scholar 

  46. Tiengo A., Fedele D., Muggeo M., Crepaldi G.: Diabetic-Like Behaviour of Glucagon Secretion in Primary Endogenous Hypertriglyceridemia — 8th Congr. Int. Diabetes Fed., Bruxelles 1973. Excerpta Medica Foundation, Amsterdam, 1973; p. 47, abstract # 110.

    Google Scholar 

  47. Tzagournis M., Chiles R., Herrold J., Skillman T. G.: The Role of Endogenous Insulin in Different Hyperlipidemic States — Diabetologia8, 215, 1972.

    Article  PubMed  CAS  Google Scholar 

  48. Tzagournis M., Chiles R., Ryan J. M., Skillman T. G.: Interrelationship of Hyperinsulinism and Hypertriglyceridemia in Young Patients with Coronary Heart Disease — Circulation38, 1156, 1968.

    PubMed  CAS  Google Scholar 

  49. Watson D.: A Simple Method for the Determination of Serum Cholesterol — Clin. chim. Acta5, 637, 1960.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Clinica Medica Generale dell’Università di Padova, Via Giustiniani 2, 35100, Padova, Italy

    Antonio Tiengo, Michele Muggeo, Domenico Fedele, Elisa Marchiori & Gaetano Crepaldi

Authors
  1. Antonio Tiengo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michele Muggeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Domenico Fedele
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisa Marchiori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gaetano Crepaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

CNR Grant no. 71.0084/04.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiengo, A., Muggeo, M., Fedele, D. et al. Insulin secretion in hyperlipoproteinemias. Acta diabet. lat 11, 149–164 (1974). https://doi.org/10.1007/BF02581314

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02581314

Key-words

Search

Navigation